These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9495631)
1. Endothelial function as intermediary endpoint in hypertension: comments. Kiowski W Blood Press Suppl; 1997; 2():71-5. PubMed ID: 9495631 [TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockers, endothelial dysfunction, and combination therapy. Schulman IH; Zachariah M; Raij L Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172 [TBL] [Abstract][Full Text] [Related]
3. Measures of endothelial function as an endpoint in hypertension? Hedner T; Sun X Blood Press Suppl; 1997; 2():58-66. PubMed ID: 9495629 [TBL] [Abstract][Full Text] [Related]
4. [Markers of endothelial function in the early stages of essential hypertension and the effect of antihypertensive therapy]. Remková A; Remko M Vnitr Lek; 2010 Dec; 56(12):1210-6. PubMed ID: 21261107 [TBL] [Abstract][Full Text] [Related]
5. The role of statins in endothelial dysfunction in hypertension. Sarkar K; Sinha AK; Mehta JL Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200 [TBL] [Abstract][Full Text] [Related]
6. A rationale for treatment of endothelial dysfunction in hypertension. Ruschitzka F; Corti R; Noll G; Lüscher TF J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841 [TBL] [Abstract][Full Text] [Related]
7. Targeting endothelial dysfunction in hypertensive subjects. Thuillez C; Richard V J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029 [TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition. Neutel JM Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535 [TBL] [Abstract][Full Text] [Related]
9. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Miller AL Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191 [TBL] [Abstract][Full Text] [Related]
10. Hydroxyhydroquinone interferes with the chlorogenic acid-induced restoration of endothelial function in spontaneously hypertensive rats. Suzuki A; Fujii A; Jokura H; Tokimitsu I; Hase T; Saito I Am J Hypertens; 2008 Jan; 21(1):23-7. PubMed ID: 18091740 [TBL] [Abstract][Full Text] [Related]
11. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Schiffrin EL Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629 [TBL] [Abstract][Full Text] [Related]
12. [Anti-hypertensive drugs associated with the improvement of endothelial function]. Yoshimoto T; Hirata Y Nihon Rinsho; 2004 Jan; 62(1):128-34. PubMed ID: 14737845 [TBL] [Abstract][Full Text] [Related]
13. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function. Neutel JM J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263 [TBL] [Abstract][Full Text] [Related]
14. Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension. Santoso T Curr Hypertens Rep; 2000 Jun; 2(3):227-9. PubMed ID: 10981153 [No Abstract] [Full Text] [Related]
15. Endothelial progenitor cells: biology and therapeutic potential in hypertension. van Zonneveld AJ; Rabelink TJ Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):167-72. PubMed ID: 16481884 [TBL] [Abstract][Full Text] [Related]
16. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension. Koh KK; Quon MJ; Lee SJ; Han SH; Ahn JY; Kim JA; Chung WJ; Lee Y; Shin EK Diabetes Care; 2007 Jun; 30(6):1605-7. PubMed ID: 17351278 [No Abstract] [Full Text] [Related]